July 4th 2025
Take a look through all the regulatory milestones in urology from the first half of the 2025.
Case 2: A 68-Year-Old Woman With Non–Muscle-Invasive Bladder Cancer
June 2nd 2025Panelists discuss how to manage the treatment of a 68-year-old woman with painless intermittent hematuria and positive cytology for high-grade urothelial cancer, addressing gender differences in diagnosis timing, the importance of repeat transurethral resection (TURBT) procedures, BCG therapy options, and considerations for radical cystectomy with pelvic organ preservation when BCG fails.
Mixed results reported for nivolumab/ipilimumab in cisplatin-ineligible mUC
June 1st 2025"The pre-specified thresholds for statistical significance were not met for the dual primary end points of overall survival in cisplatin-ineligible and PD-L1 positive patients," said Michiel Van der Heijden, MD, PhD.
Case 1: A 79-Year-Old Man With Non–Muscle-Invasive Bladder Cancer
May 23rd 2025Panelists discuss how they approach a typical bladder cancer case of a 79-year-old man with hematuria, including initial diagnostic procedures, the importance of proper tumor measurement during resection, BCG therapy protocols, and management options for BCG-unresponsive disease with a focus on nadofaragene firadenovec (Adstiladrin).